Form 4: Edgewell (EPC) CAO reports 3,586 restricted stock equivalents

Rhea-AI Filing Summary

Edgewell Personal Care Co. (EPC) reported an equity award to its Chief Accounting Officer, John M. Dunham, in a Form 4 filing. On 11/14/2025, he received 3,586 restricted stock equivalents at a price of $0 per unit. These awards are scheduled to vest in three equal installments on 11/14/2026, 11/14/2027, and 11/14/2028, converting into shares of Edgewell common stock as they vest. Vesting requires continued employment on each vesting date, although all or a portion may vest earlier in cases such as death, disability, change in control, or certain termination events.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DUNHAM JOHN M

(Last) (First) (Middle)

C/O EDGEWELL PERSONAL CARE COMPANY

6 RESEARCH DRIVE

(Street)

SHELTON CT 06484

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EDGEWELL PERSONAL CARE Co [ EPC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
11/14/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Equivalents 11/14/2025	$0	11/14/2025		A		3,586		11/14/2026(1)	(1)	Common Stock	3,586	$0	3,586	D

Explanation of Responses:

1. One-third of the RSEs will vest and convert into shares of Edgewell common stock on each of 11/14/2026, 11/14/2027 and 11/14/2028 if the Reporting Person is employed on said dates, or all or a portion may vest upon death, disability, change in control or certain termination events.

	/s/ John M. Dunham	11/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Edgewell Personal Care Co. (EPC) report in this Form 4?

Edgewell Personal Care Co. reported that its Chief Accounting Officer, John M. Dunham, received an award of 3,586 restricted stock equivalents on 11/14/2025.

How many restricted stock equivalents were granted to the EPC officer and at what price?

The officer received 3,586 restricted stock equivalents, each with a stated price of $0, which will convert into shares of Edgewell common stock upon vesting.

What is the vesting schedule for the 3,586 restricted stock equivalents at EPC?

One-third of the 3,586 restricted stock equivalents will vest and convert into common shares on each of 11/14/2026, 11/14/2027, and 11/14/2028, if the officer remains employed on those dates.

Under what conditions can the EPC restricted stock equivalents vest early?

All or a portion of the restricted stock equivalents may vest earlier in the event of death, disability, a change in control, or certain termination events, as described in the award terms.

Who is the reporting person in the EPC Form 4 and what is their role?

The reporting person is /s/ John M. Dunham, who is identified as an officer of Edgewell Personal Care Co. with the title Chief Accounting Officer.

How many derivative securities does the EPC officer beneficially own after the transaction?

Following the reported transaction, the officer beneficially owns 3,586 derivative securities in the form of restricted stock equivalents, held with direct ownership.